The company’s quarterly profit rose from $1.62 billion in the same period last year, reaching $4.68 per share. When accounting for one-time items, adjusted earnings hit $6.03 per share, comfortably beating the $5.72 consensus estimate tracked by FactSet. Total revenue reached $11.99 billion, outpacing the $11.71 billion projected by market analysts.

Chief Executive Marc Casper attributed the financial momentum to gains in market share and robust performance across the company’s core end markets. During the quarter, Thermo Fisher introduced several new platforms integrating AI analytics and opened a dedicated bioprocess design center in Massachusetts to accelerate drug development support. Management plans to provide updated fiscal guidance during their upcoming investor conference call.